BioMarin Pharmaceutical (BM8) Q2 2025 Earnings Report
DE:BM8 Q2 2025 EPS Results
- Actual EPS
- EUR 1.10
- Consensus EPS
- EUR 0.77
- Beat/Miss
- Beat by +EUR 0.33
- One Year Ago EPS
- EUR 0.49
DE:BM8 Q2 2025 Revenue Results
- Actual Revenue
- EUR 739.85M
- Expected Revenue
- EUR 681.26M
- Beat/Miss
- Beat by +EUR 58.59M
- YoY Revenue Growth
- +16.77%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/04/2025
- Time
- After Close
- Conference Call
- Monday, August 4, 2025
DE:BM8 Upcoming Earnings
BioMarin Pharmaceutical's next earnings date is estimated for February 24, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
DE:BM8 Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:BM8 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 24, 2027 | 2026 (Q4) | 0.99- | -0.21 | ― | ― |
| Nov 02, 2026 | 2026 (Q3) | -0.040.21 | -0.14 | 243.75% (+0.35) | |
| Aug 06, 2026 | 2026 (Q2) | 0.851.07 | 1.1 | -2.44% (-0.03) | |
| May 04, 2026 | 2026 (Q1) | 0.620.68 | 0.85 | -20.00% (-0.17) | |
| Feb 23, 2026 | 2025 (Q4) | 0.15-0.21 | 0.57 | -137.50% (-0.79) | |
| Oct 27, 2025 | 2025 (Q3) | -0.25-0.14 | 0.49 | -129.09% (-0.63) | |
| Aug 04, 2025 | 2025 (Q2) | 0.771.10 | 0.49 | 123.64% (+0.61) | |
| May 01, 2025 | 2025 (Q1) | 0.640.85 | 0.41 | 106.52% (+0.44) | |
| Feb 19, 2025 | 2024 (Q4) | 0.480.57 | 0.1 | 481.82% (+0.47) | |
| Oct 29, 2024 | 2024 (Q3) | 0.470.49 | 0.19 | 161.90% (+0.30) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
